340 related articles for article (PubMed ID: 19036684)
1. [The value of chemoradiotherapy in the management of locally advanced pancreatic adenocarcinoma: systematic review].
Azria D; Seblain-El-Guerche C; Girard N; Hennequin C; Huguet F
Bull Cancer; 2008 Nov; 95(11):1116-30. PubMed ID: 19036684
[TBL] [Abstract][Full Text] [Related]
2. [Systematic review: value of perioperative chemotherapy in the management of resectable rectal adenocarcinoma (brief report)].
Bécouarn Y; Guillo S; Artru P; Assenat E; Bosset JF; Conroy T; François E; Taïeb J; Touboul E
Bull Cancer; 2008; 95(7):717-34. PubMed ID: 18763385
[TBL] [Abstract][Full Text] [Related]
3. Chemoradiotherapy in the management of locally advanced pancreatic carcinoma: a qualitative systematic review.
Huguet F; Girard N; Guerche CS; Hennequin C; Mornex F; Azria D
J Clin Oncol; 2009 May; 27(13):2269-77. PubMed ID: 19307501
[TBL] [Abstract][Full Text] [Related]
4. Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies.
Huguet F; André T; Hammel P; Artru P; Balosso J; Selle F; Deniaud-Alexandre E; Ruszniewski P; Touboul E; Labianca R; de Gramont A; Louvet C
J Clin Oncol; 2007 Jan; 25(3):326-31. PubMed ID: 17235048
[TBL] [Abstract][Full Text] [Related]
5. WITHDRAWN: Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer.
Yip D; Karapetis C; Strickland A; Steer CB; Goldstein D
Cochrane Database Syst Rev; 2009 Oct; 2009(4):CD002093. PubMed ID: 19821291
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer.
Yip D; Karapetis C; Strickland A; Steer CB; Goldstein D
Cochrane Database Syst Rev; 2006 Jul; (3):CD002093. PubMed ID: 16855985
[TBL] [Abstract][Full Text] [Related]
7. Sequential neoadjuvant chemoradiotherapy (CRT) followed by curative surgery vs. primary surgery alone for resectable, non-metastasized pancreatic adenocarcinoma: NEOPA- a randomized multicenter phase III study (NCT01900327, DRKS00003893, ISRCTN82191749).
Tachezy M; Gebauer F; Petersen C; Arnold D; Trepel M; Wegscheider K; Schafhausen P; Bockhorn M; Izbicki JR; Yekebas E
BMC Cancer; 2014 Jun; 14():411. PubMed ID: 24906700
[TBL] [Abstract][Full Text] [Related]
8. [Locally advanced pancreatic adenocarcinoma. Chemoradiotherapy, reevaluation and secondary resection].
Delpero JR; Turrini O
Cancer Radiother; 2006 Nov; 10(6-7):462-70. PubMed ID: 16987678
[TBL] [Abstract][Full Text] [Related]
9. [Possibilities of palliation in pancreatic cancer].
Di Costanzo F; Sdrobolini A; Gasperoni S
Tumori; 1999; 85(1 Suppl 1):S47-53. PubMed ID: 10235081
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy technical considerations in the management of locally advanced pancreatic cancer: American-French consensus recommendations.
Huguet F; Goodman KA; Azria D; Racadot S; Abrams RA
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1355-64. PubMed ID: 22768988
[TBL] [Abstract][Full Text] [Related]
11. Intraoperative and conformal external-beam radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic carcinoma.
Furuse J; Kinoshita T; Kawashima M; Ishii H; Nagase M; Konishi M; Nakagohri T; Inoue K; Ogino T; Ikeda H; Maru Y; Yoshino M
Cancer; 2003 Mar; 97(5):1346-52. PubMed ID: 12599244
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy in the adjuvant management of pancreatic adenocarcinoma.
Abrams RA
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S30-2. PubMed ID: 16399427
[TBL] [Abstract][Full Text] [Related]
13. [Standards, options and recommendations: concomitant radiochemotherapy for cancer of the cervix: a critical analysis of the literature and update of SOR].
Haie-Meder C; Fervers B; Chauvergne J; Fondrinier E; Lhommé C; Guastalla JP; Resbeut M
Bull Cancer; 1999 Oct; 86(10):829-41. PubMed ID: 10572234
[TBL] [Abstract][Full Text] [Related]
14. Preoperative chemoradiation in adenocarcinoma of the pancreas. A single centre experience advocating a new treatment strategy.
Golcher H; Brunner T; Grabenbauer G; Merkel S; Papadopoulos T; Hohenberger W; Meyer T
Eur J Surg Oncol; 2008 Jul; 34(7):756-64. PubMed ID: 18191528
[TBL] [Abstract][Full Text] [Related]
15. A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282.
Cohen SJ; Dobelbower R; Lipsitz S; Catalano PJ; Sischy B; Smith TJ; Haller DG;
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1345-50. PubMed ID: 16029791
[TBL] [Abstract][Full Text] [Related]
16. A systematic review and network meta-analysis of phase III randomised controlled trials for adjuvant therapy following resection of pancreatic ductal adenocarcinoma (PDAC).
Kamarajah SK; Bundred JR; Alrawashdeh W; Manas D; White SA
HPB (Oxford); 2020 May; 22(5):649-659. PubMed ID: 31894014
[TBL] [Abstract][Full Text] [Related]
17. GRECCAR 14 - a multicentric, randomized, phase II-III study evaluating the tailored management of locally advanced rectal carcinoma after a favourable response to induction chemotherapy: Study protocol.
Rouanet P; Castan F; Mazard T; Lemanski C; Nougaret S; Deshayes E; Chalbos P; Gourgou S; Taoum C;
Colorectal Dis; 2023 Oct; 25(10):2078-2086. PubMed ID: 37697712
[TBL] [Abstract][Full Text] [Related]
18. Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II study.
Al-Sukhun S; Zalupski MM; Ben-Josef E; Vaitkevicius VK; Philip PA; Soulen R; Weaver D; Adsay V; Heilbrun LK; Levin K; Forman JD; Shields AF
Am J Clin Oncol; 2003 Dec; 26(6):543-9. PubMed ID: 14663369
[TBL] [Abstract][Full Text] [Related]
19. Treatment Approaches to Locally Advanced Pancreatic Adenocarcinoma.
Pollom EL; Koong AC; Ko AH
Hematol Oncol Clin North Am; 2015 Aug; 29(4):741-59. PubMed ID: 26226908
[TBL] [Abstract][Full Text] [Related]
20. Open-label, multicenter, randomized phase III trial of adjuvant chemoradiation plus interferon Alfa-2b versus fluorouracil and folinic acid for patients with resected pancreatic adenocarcinoma.
Schmidt J; Abel U; Debus J; Harig S; Hoffmann K; Herrmann T; Bartsch D; Klein J; Mansmann U; Jäger D; Capussotti L; Kunz R; Büchler MW
J Clin Oncol; 2012 Nov; 30(33):4077-83. PubMed ID: 23008325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
